Gapping down
In reaction to disappointing earnings/guidance:
- SCS -16.6%, ACN -3%, CACI -1.4%
Other news:
- ESNC -26.1% (to offer newly issued shares of common stock pursuant to an underwritten public offering)
- KMDA -26% (withdraws Marketing Authorization Application for its proprietary inhaled Alpha-1 Antitrypsin therapy for the treatment of Alpha-1 Antitrypsin Deficiency with the European Medicines Agency)
- JCAP -8.4% (announces commencement of public offering of common stock)
- WB -7.6% (vague chatter that regulators may have ordered the company to halt audio and video programming services)
- PZRX -5% (files mixed securities shelf offering with proposed maximum aggregate offering price of $15 mln)
- SINA -5% (in sympathy with WB)
- SBPH -4.8% (announces proposed public offering of common stock)
- TMHC -4.1% (prices 10 mln shares of common stock)
- STM -3.4% (announces a $1.5 bln dual-tranche offering of New Convertible Bonds, the early redemption of its 2019 Convertible Bonds, the launch of a share buy-back program)
- JD -1.3% (invests $397 million in Farfetch)
Analyst comments:
- CNK -0.8% (downgraded to Underperform at Credit Suisse)